Marshall Wace North America’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $4.85M | Sell |
13,003
-421,333
| -97% | -$157M | 0.02% | 518 |
|
|
2021
Q2 | $166M | Sell |
434,336
-341,135
| -44% | -$130M | 0.69% | 21 |
|
|
2021
Q1 | $278M | Sell |
775,471
-72,377
| -9% | -$26M | 1.15% | 9 |
|
|
2020
Q4 | $272M | Buy |
847,848
+613,872
| +262% | +$197M | 1.23% | 9 |
|
|
2020
Q3 | $62.8M | Buy |
233,976
+83,708
| +56% | +$22.5M | 0.4% | 55 |
|
|
2020
Q2 | $39.5M | Buy |
150,268
+141,142
| +1,547% | +$37.1M | 0.26% | 98 |
|
|
2020
Q1 | $2.07M | Buy |
9,126
+5,196
| +132% | +$1.18M | 0.02% | 473 |
|
|
2019
Q4 | $1.19M | Buy |
3,930
+2,462
| +168% | +$744K | 0.01% | 687 |
|
|
2019
Q3 | $353K | Sell |
1,468
-16,304
| -92% | -$3.92M | ﹤0.01% | 865 |
|
|
2019
Q2 | $5.02M | Sell |
17,772
-353,403
| -95% | -$99.7M | 0.03% | 361 |
|
|
2019
Q1 | $107M | Buy |
371,175
+347,887
| +1,494% | +$99.8M | 0.75% | 29 |
|
|
2018
Q4 | $6.12M | Sell |
23,288
-1,474
| -6% | -$387K | 0.06% | 221 |
|
|
2018
Q3 | $6.79M | Buy |
24,762
+15,253
| +160% | +$4.18M | 0.05% | 264 |
|
|
2018
Q2 | $2.26M | Sell |
9,509
-288
| -3% | -$68.5K | 0.01% | 734 |
|
|
2018
Q1 | $2.15M | Buy |
9,797
+2,855
| +41% | +$627K | 0.01% | 797 |
|
|
2017
Q4 | $1.56M | Sell |
6,942
-35,475
| -84% | -$7.98M | 0.01% | 900 |
|
|
2017
Q3 | $8.06M | Buy |
42,417
+37,761
| +811% | +$7.17M | 0.05% | 423 |
|
|
2017
Q2 | $875K | Buy |
+4,656
| New | +$875K | 0.01% | 966 |
|